Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - STOCK-BASED COMPENSATION
Stock-based Compensation LGVN - Longeveron Inc.
2.03 M
LAST VALUE
-48.76%
2 YEAR CAGR
36.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR